{
  "retracted": false,
  "timestamp": 1572912000000,
  "updates": [
    {
      "timestamp": 1571330434051,
      "identifier": {
        "doi": "10.1016/j.ejphar.2019.172656"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.ejphar.2018.08.016"
  },
  "journal": "European Journal of Pharmacology",
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “The novel peripherally active cannabinoid type 1 and serotonin type 3 receptor agonist AM9405 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome” [Eur. J. Pharmacol. (2018), 836 34–43]"
}
